首頁 > 市場調查報告書 > 醫療設備

眼科設備

市場調查報告書

商品編碼

1529370

全球玻璃體切割設備市場 - 2024-2031

Global Vitrectomy Devices Market - 2024-2031

出版日期: 2024年08月06日 | 出版商:

DataM Intelligence | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

2023年，全球玻璃體切割設備市場達到12.162億美元，預計2031年將達到21.213億美元，2024-2031年預測期間複合年成長率為7.2%。

玻璃體切除裝置是眼科中使用的醫療器械，用於在稱為玻璃體切除術的手術過程中從患者的眼睛中去除玻璃體液（一種填充眼睛中心的透明凝膠狀物質）。玻璃體切除術用於治療各種眼部疾病，例如視網膜剝離、糖尿病視網膜病變、視網膜前膜和黃斑裂孔。

玻璃體被透明液體或氣泡取代，直到身體再次開始產生玻璃體。該市場的促進因素包括糖尿病視網膜病變和視網膜剝離的盛行率不斷上升、玻璃體切除手術的技術進步以及眼科手術數量的增加將推動該市場的成長。

市場動態：

司機

糖尿病視網膜病變和視網膜剝離的盛行率不斷增加

全球玻璃體切割設備市場的需求是由多種因素所驅動的。關鍵因素之一是糖尿病視網膜病變的盛行率不斷增加，預計視網膜剝離將推動玻璃體切除術設備市場的發展。

糖尿病視網膜病變是造成工作年齡成年人視力喪失的主要原因，由於全球糖尿病盛行率不斷上升，其發生率正在上升。根據 2024 年 2 月出版的《阿育吠陀與綜合醫學雜誌》，糖尿病視網膜病變 (DR) 是糖尿病最常見的微血管併發症。在全球範圍內，糖尿病患者中糖尿病視網膜病變的盛行率估計為 27.0%，導致全球 40 萬人失明。它會影響視網膜的血管。它通常會影響雙眼，如果不及時治療，可能會導致視力喪失。

根據 NCBI 2022 年 1 月的研究，基於對各種醫院研究的總結分析，據報導，非洲 DR 盛行率為 31.6%，衣索比亞為 19.48%。根據世界衛生組織 (WHO) 估計，全球 3,700 萬例失明病例是由 DR 造成的。

視網膜剝離（RD）是一種嚴重的眼部疾病，可能導致永久性視力喪失，這也增加了對玻璃體切除設備的需求。孔源性視網膜剝離 (RRD) 是一種威脅視力的疾病，估計在美國每年每 10 萬人中有 10 至 18 人患有孔源性視網膜剝離。 8% 至 16% 的急性症狀性 PVD 患者會出現視網膜裂孔，如果不治療，30% 至 50% 的患者可能會進展為 RRD。

限制

玻璃體切除術設備的高成本、患者不適和與治療相關的風險、缺乏熟練的醫療保健專業人員以及嚴格的監管要求等因素預計將阻礙市場的發展。

有關此報告的更多詳細資訊 - 索取樣本

Vitrectomy devices are medical instruments used in ophthalmology to remove the vitreous humor, a clear gel-like substance that fills the center of the eye, from a patient's eye during a surgical procedure called vitrectomy. Vitrectomy is performed to treat various eye conditions such as retinal detachments, diabetic retinopathy, epiretinal membranes, and macular holes.

The vitreous is replaced with a clear fluid or a gas bubble until the body begins producing the vitreous again. The market is driven by factors such as the increasing prevalence of diabetic retinopathy and retinal detachment, technological advancement in vitrectomy surgical procedures and the rising number of eye surgical procedures would drive this market growth.

Market Dynamics: Drivers

Increasing prevalence of diabetic retinopathy and retinal detachment

The demand for the global vitrectomy devices market is driven by multiple factors. One of the key factors is the increasing prevalence of diabetic retinopathy and retinal detachment is expected to drive the vitrectomy devices market.

Diabetic retinopathy is a leading cause of vision loss among working-age adults, and its incidence is rising due to the growing prevalence of diabetes globally. According to the Journal of Ayurveda and Integrated Medical Science publication in February 2024, Diabetic retinopathy (DR) is the most frequent microvascular complication of Diabetes mellitus. Globally the prevalence of Diabetic retinopathy among diabetic patients is estimated to be 27.0% which leads to 0.4 million blindness in the world. It affects blood vessels in the retina. It commonly affects both eyes and can lead to vision loss if left untreated.

As per NCBI research studies in January 2022, based on a pooled analysis of various hospital-based studies the prevalence of DR is reported to be 31.6% in Africa and 19.48%in Ethiopia. According to the World Health Organization (WHO), it is estimated that DR makes up 37 million cases of blindness in the world.

Retinal detachments (RDs) constitute a severe ocular condition that can lead to permanent vision loss is also contribute to the demand for vitrectomy devices. Rhegmatogenous retinal detachment (RRD) is a vision-threatening condition with an estimated incidence of 10 to 18 per 100,000 population per year in the United States. Retinal breaks are identified in 8% to 16% of patients with acute symptomatic PVD and may progress to RRD in 30% to 50% of patients if untreated.

Restraints

Factors such as the high cost of vitrectomy devices, patient discomfort & risk associated with the treatment, lack of skilled healthcare professionals, and stringent regulatory requirements, are expected to hamper the market.

For more details on this report - Request for Sample

Segment Analysis

The global vitrectomy devices are segmented based on product type, application, end-users, and region.

The vitrectomy machines segment accounted for approximately 49.6% of the global vitrectomy devices market share

The vitrectomy machines segment is expected to hold the largest market share over the forecast period. Vitrectomy machines are the key equipment used in vitrectomy procedures, which involve the removal of the vitreous humor from the eye to treat various conditions. These machines are designed to precisely control the removal of the vitreous and provide surgeons with improved visibility and control during the operation.

Vitrectomy machines such as Alcon Constellation, DORC EVA Bausch + Lomb Stellaris PC, Associate 6000 Dual, Associate 2500 Compact System, and Syntec VitMan Vitrectomy System are some of the vitrectomy devices and systems used for treating the conditions such as retinal detachments, vitreous hemorrhage, endophthalmitis, and macular holes. The development of new generation machines with advanced features such as improvised fluidics, high cut rates, small gauge size, and intraocular pressure control helps to drive this segment's growth.

Moreover, key players strategies such as partnerships & collaborations, technological advancements in the devices, and major players' innovative launches would propel this segment's growth in the market. For instance, in January 2022, DORC International and WEFIS GmbH are excited to announce a strategic partnership, based on an equity investment by DORC. The partnership will focus on research and development to deliver innovation in the performance, efficiency, and usability of instruments for cataract surgery.

Also, in March 2022, DORC International announced the launch of Eva Nexus, a device designed to improve efficiency and control in the retina, cataract, and combined surgery. Surgeons have used Eva Nexus in more than 1,500 surgical procedures during the limited-release phase.

Similarly, in August 2022, Vortex Surgical launched the TID Pharos Illuminated Depressor the first standalone transilluminator that can be used across all existing vitrectomy machine platforms without requiring a skilled assistant. The product is the second generation of the company's line of transillumination products, which includes the first-generation Todorich Illuminated Depressor.

Geographical Analysis

North America accounted for approximately 43.2% of the global vitrectomy devices market share

North America region is expected to hold the largest market share over the forecast period. Owing to the growing prevalence of ophthalmic disorders such as diabetic retinopathy, macular hole, and retinal detachment, & well advanced healthcare infrastructure, is expected to contribute towards the growth of the market in the region.

Moreover, major key players' presence, financial investments, product launches, and approvals would drive this market growth in this region. For instance, in August 2022, Iantrek Inc. announced the closing of a $23M Series B financing. The oversubscribed financing was led by institutional investors Visionary Ventures and Sectoral Asset Management, Inc. According to the company, the capital will be used to initiate clinical introduction and post-marketing studies of Iantrek's micro-interventional glaucoma surgical (MIGS) devices in the United States.

Also, in April 2023, Nova Eye Medical Limited announced that it has been granted U.S. Food and Drug Administration (FDA) 510(k) clearance for its iTrack Advance, a new canaloplasty device.

Similarly, in June 2024, Alcon announced that UNITY Vitreoretinal Cataract System (VCS) and UNITY Cataract System (CS) have received U.S. Food and Drug Administration (FDA) 510(k) clearance. These innovations are the first to be introduced from Alcon's highly anticipated Unity portfolio.

Market Segmentation

By Product Type

Vitrectomy Machines
Vitrectomy packs
Photocoagulation lasers
Illumination devices
Others

By Application

Diabetic Retinopathy
Retinal Detachment
Macular Hole
Vitreous Hemorrhage
Others

By End-users

Hospitals
Ophthalmology Clinics
Ambulatory Surgical Centers

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- U.K.
- France
- Spain
- Italy
- Rest of Europe
South America
- Brazil
- Argentina
- Rest of South America
Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Middle East and Africa

Competitive Landscape

The major global players in the vitrectomy devices market include Alcon, Bausch Health Companies Inc., BVI, DORC Holding B.V., Johnson & Johnson, NIDEK CO., LTD., Blink Medical, Topcon Corporation, Carl Zeiss Meditec AG, Hoya Surgical Optics

Key Developments

In April 2024, Carl Zeiss Meditec AG announced that, after securing all required regulatory approvals, it has completed the acquisition of 100% of D.O.R.C. (Dutch Ophthalmic Research Center) from the investment firm Eurazeo SE, Paris, France. The acquisition enhances and complements ZEISS Medical Technology's broad ophthalmic portfolio and range of digitally connected workflow solutions for addressing a wide variety of eye conditions, spanning retina and cornea disorders, cataracts, glaucoma, and refractive errors.
In June 2023, ZEISS introduced revolutionary VISUMAX 800 and Quatera 700 medical devices in Bangladesh. VISUMAX 800 enables surgeons to perform corneal refractive surgeries, such as LASIK and SMILE, with unparalleled accuracy, speed, and reliability. This innovative device offers superior patient comfort, faster recovery times, and exceptional visual outcomes, reinforcing ZEISS's commitment to advancing eye care solutions in Bangladesh.

Why Purchase the Report?

To visualize the global vitrectomy devices market segmentation based on product type, application, end-users, and region, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of vitrectomy devices market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as Excel consisting of key products of all the major players.

The global vitrectomy devices market report would provide approximately 62 tables, 59 figures, and 183 pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Application
3.3. Snippet by End-users
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing Prevalence of Diabetic Retinopathy and Retinal Detachment
  - 4.1.1.2. Technological Advancement in Vitrectomy Surgical Procedures
- 4.1.2. Restraints
  - 4.1.2.1. High Cost of Vitrectomy Devices
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. By Product Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 6.1.2. Market Attractiveness Index, By Product Type
6.2. Vitrectomy Machines *
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Vitrectomy packs
6.4. Photocoagulation lasers
6.5. Illumination devices
6.6. Others

7. By Application

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application Market Attractiveness Index, By Application
7.2. Diabetic Retinopathy *
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Retinal Detachment
7.4. Macular Hole
7.5. Vitreous Hemorrhage
7.6. Others

8. By End-users

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-users
- 8.1.2. Market Attractiveness Index, By End-users
8.2. Hospitals *
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Ophthalmology Clinics
8.4. Ambulatory Surgical Centers

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-users
- 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.6.1. U.S.
  - 9.2.6.2. Canada
  - 9.2.6.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-users
- 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.6.1. Germany
  - 9.3.6.2. U.K.
  - 9.3.6.3. France
  - 9.3.6.4. Spain
  - 9.3.6.5. Italy
  - 9.3.6.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-users
- 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.6.1. Brazil
  - 9.4.6.2. Argentina
  - 9.4.6.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-users
- 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.6.1. China
  - 9.5.6.2. India
  - 9.5.6.3. Japan
  - 9.5.6.4. South Korea
  - 9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-users

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. Alcon *
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. Bausch Health Companies Inc.
11.3. BVI
11.4. DORC Holding B.V
11.5. Johnson & Johnson
11.6. NIDEK CO. LTD
11.7. Blink Medical
11.8. Topcon Corporation
11.9. Carl Zeiss Meditec AG
11.10. Hoya Surgical Optics

LIST NOT EXHAUSTIVE